| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | Chief Scientific Officer | Common Stock | 375K | $2.09M | $5.59 | Feb 12, 2025 | Direct |
| ENANTA PHARMACEUTICALS INC | Chief Scientific Officer | Stock Option (right to buy) | 87K | Nov 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | Feb 12, 2025 | 2 | -$24.2K | 4 | Feb 14, 2025 | Chief Scientific Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 6, 2024 | 1 | -$20.9K | 4 | Dec 10, 2024 | Chief Scientific Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2024 | 1 | -$13.7K | 4 | Dec 3, 2024 | Chief Scientific Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 27, 2024 | 1 | $0 | 4 | Nov 27, 2024 | Chief Scientific Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Feb 12, 2024 | 2 | -$13.4K | 4 | Feb 14, 2024 | Chief Scientific Officer |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 5, 2023 | 1 | -$23.2K | 4 | Dec 6, 2023 | Sr. VP, R&D & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2023 | 1 | -$15.1K | 4 | Dec 5, 2023 | Sr. VP, R&D & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 22, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Sr. VP, R&D & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Mar 15, 2023 | 4 | -$424K | 4 | Mar 17, 2023 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Feb 13, 2023 | 3 | -$409K | 4 | Feb 15, 2023 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2022 | 1 | -$46.8K | 4 | Dec 5, 2022 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 23, 2022 | 2 | $0 | 4 | Nov 28, 2022 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Feb 14, 2022 | 3 | -$59.6K | 4 | Feb 15, 2022 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Dec 1, 2021 | 1 | -$48.8K | 4 | Dec 3, 2021 | Sr. VP & CSO |
| ENTA | ENANTA PHARMACEUTICALS INC | Nov 19, 2021 | 2 | $0 | 4 | Nov 23, 2021 | Sr. VP & CSO |